Biography

Dr. M.R.A. Pillai Ph.D, D.Sc is a radiopharmaceuticals scientist with over forty years experience. Dr. Pillai obtained B.Sc degree from Kerala University, M.Sc and PhD degrees from University of Mumbai; and D.Sc degree from the Institute of Nuclear Chemistry and Technology (INCT), Poland. Dr. Pillai worked as a scientist from 1976-2000; as Head, Radiopharmaceuticals Division, Bhabha Atomic Research Centre during 2000-2003 and 2011-2013. Dr. Pillai worked at the University of Missouri-Columbia as Post Doctoral Research Associate, Visiting Assistant Professor and Visiting Professor during 1997 to 1994. Dr. Pillai worked as Technical Officer at the International Atomic Energy Agency (IAEA) during 2003-2010. At present Dr. Pillai works as Group Director in Molecular Cyclotrons, Cochin, Kerala. Dr. Pillai has carried out extensive research in radioimmunoassay, radioisotope production and radiopharmaceuticals chemistry. His experience in radiopharmaceuticals chemistry includes SPECT, PET and therapeutic radiopharmaceuticals development and production. He is an expert in isotope production using both reactor and cyclotron; and experienced in setting up medical cyclotrons. Dr. authored over 180 publications including 30 review articles, holds 2 US patents, and presented over one hundred invited lectures. He is an author of three books. At the IAEA he was responsible for conceiving, editing and publication of 13 IAEA books; including the series of four books on ‘Cyclotron Produced Radionuclides’, three books on technetium-99m and four books on therapeutic radiopharmaceuticals and radionuclide generators. Dr. Pillai visited more than 50 countries in connection with his IAEA work. Dr. Pillai received six IAEA awards during the seven year (2003-2010) tenure including a Distinguished Service award, a Merit award, and best publication awards.


Research Interest

Maroor Raghavan Ambikalmajan Pillai Research Interests are Isotope production using reactor and cyclotron, radiopharmaceuticals chemistry, SPECT, PET and therapeutic radiopharmaceuticals, synthetic organic chemistry and radioimmunoassay.